HEI issues RFIQ to study health effects of air pollution in India

HEI has issued RFIQ 21-3, Studies of Air Pollution and Health Effects in India, to identify and fund scientific teams to conduct epidemiologic studies of exposure to air pollution and cardiovascular and respiratory disease or other relevant health outcomes in India.

NOTE: In light of the growing COVID-19 cases in India, the deadline for submission of statements for air pollution & health effects research in India under HEI RFIQ 21-3 has been extended to February 11, 2022.

This RFIQ seeks to identify scientific teams to conduct epidemiologic studies of exposure to air pollution and cardiovascular and respiratory disease or other relevant health outcomes in India. Topics of interest include:  

• Exposure to air pollution during high-pollution events (i.e., air pollution episodes) and mortality or other health outcomes 
• Exposure to air pollution and health outcomes in the first 1,000 days after birth (fetal growth, birth weight, lung growth, child development and stunting, cognitive development, etc.) 
• Long-term exposure to air pollution and all-cause and cause-specific mortality (e.g., mortality due to cardiovascular disease, respiratory diseases such as chronic obstructive pulmonary disease [COPD], stroke, cancer, and diabetes)
• Short-term exposure to air pollution and mortality due to cardiovascular disease, COPD, stroke, cancer, diabetes, etc. 
• Long-term exposure to air pollution and incidence of cardiovascular disease and respiratory diseases, such as COPD, stroke, cancer, diabetes, etc.    

More detailed information can be found here.

To stay informed regarding this and future funding opportunities, check our Funding page or follow us on Twitter.